These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23260985)

  • 1. Role of body mass index in acute charcot neuroarthropathy.
    Ross AJ; Mendicino RW; Catanzariti AR
    J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
    Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
    Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charcot neuroarthropathy: An often overlooked complication of diabetes.
    Botek G; Anderson MA; Taylor R
    Cleve Clin J Med; 2010 Sep; 77(9):593-9. PubMed ID: 20810870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.
    Korzon-Burakowska A; Jakóbkiewicz-Banecka J; Fiedosiuk A; Petrova N; Koblik T; Gabig-Cimińska M; Edmonds M; Małecki MT; Węgrzyn G
    Diabet Med; 2012 Jun; 29(6):771-5. PubMed ID: 21913967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Charcot joint: a modern neurologic perspective.
    Chisholm KA; Gilchrist JM
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):1-13. PubMed ID: 22361621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
    Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcot neuroarthropathy in diabetes mellitus.
    Rajbhandari SM; Jenkins RC; Davies C; Tesfaye S
    Diabetologia; 2002 Aug; 45(8):1085-96. PubMed ID: 12189438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
    Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis.
    Grear BJ; Rabinovich A; Brodsky JW
    Foot Ankle Int; 2013 Nov; 34(11):1541-7. PubMed ID: 23900228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
    Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot arthropathy risk elevation in the obese diabetic population.
    Stuck RM; Sohn MW; Budiman-Mak E; Lee TA; Weiss KB
    Am J Med; 2008 Nov; 121(11):1008-14. PubMed ID: 18954849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot neuroarthropathy triggered and complicated by osteomyelitis. How limb salvage can be achieved.
    Aragón-Sánchez J; Lázaro-Martínez JL; Quintana-Marrero Y; Álvaro-Afonso FJ; Hernández-Herrero MJ
    Diabet Med; 2013 Jun; 30(6):e229-32. PubMed ID: 23590722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
    Petrova NL; Foster AV; Edmonds ME
    Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of the acute Charcot foot in diabetes.
    Rudrappa S; Game F; Jeffcoate W
    Diabet Med; 2012 Jun; 29(6):819-21. PubMed ID: 22587408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and acute Charcot neuroarthropathy--a call for heightened vigilance.
    Iheonunekwu N; Ibrahim TM; Ojuro I
    Niger J Med; 2010; 19(2):239-40. PubMed ID: 20642098
    [No Abstract]   [Full Text] [Related]  

  • 16. Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy.
    Dallimore SM; Puli N; Kim D; Kaminski MR
    J Foot Ankle Res; 2020 Sep; 13(1):56. PubMed ID: 32928270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering mechanisms of neuroarthropathy following conservative surgery for osteomyelitis.
    Aragón-Sánchez J; Lázaro-Martínez JL; Hernández-Herrero MJ
    Diabet Med; 2010 Jul; 27(7):844-7. PubMed ID: 20636967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis.
    Lanting SM; Chan TL; Casey SL; Peterson BJ; Chuter VH
    J Foot Ankle Res; 2022 Mar; 15(1):17. PubMed ID: 35232466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic neuroarthropathy of the shoulder.
    Clayton M; Taylor BC; Backes J
    Orthopedics; 2010 Aug; 33(8):. PubMed ID: 20704097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of diabetic neuropathic ankle arthropathy by arthrodesis using an Ilizarov frame.
    Yousry AH; Abdalhady AM
    Acta Orthop Belg; 2010 Dec; 76(6):821-6. PubMed ID: 21302582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.